TORONTO — Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing renamed, lower-priced copies of the medications. Health Canada ...
Corcept Therapeutics has shown unexpected KORLYM franchise durability despite generic pressure and legal headwinds. Relacorilant's transition plan faltered after an FDA CRL, delaying lifecycle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results